Skip to main content

Advertisement

Table 4 Chemoresponse assay results (expressed as a continuous variable corresponding to categorized results (R = 3, IR = 2, NR = 1)) for metachronous tumor pairs

From: In vitro chemoresponse in metachronous pairs of gyneclologic cancers

  Number of pairs Primary median (IQR) RI SCORE Recurrent median (IQR) RI SCORE p
Carboplatin 46 2(1–3) 1(1–2) 0.06
Carboplatin/Gemcitabine 35 2(1–3) 2(2–3) 0.36
Carboplatin/Paclitaxel 41 3(1–3) 2(1–3) 0.67
Cisplatin 42 2(1–2) 2(1–2) 1.00
Docetaxel 42 1(1–2) 1(1–2) 0.51
Doxorubicin 49 1(1–2) 1(1–2) 0.89
Etoposide 39 2(1–2) 2(1–2) 0.21
Gemcitabine 48 1(1–2) 1(1–2) 0.33
Ifosfamide 30 2(1–2) 2(1–2) 0.83
Paclitaxel 47 2(1–3) 1(1–2) 0.04
Topotecan 52 1.5(1–2) 1(1–2) 0.70